{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:57:04Z","timestamp":1788029824648,"version":"build-2784847793"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.abd.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T21:00:27Z","timestamp":1701896427000},"page":"244-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unmet needs in the management of psoriasis in Latin America: a systematic review"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6049-6701","authenticated-orcid":false,"given":"Bruna","family":"Ossanai Schoenardie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-9323","authenticated-orcid":false,"given":"Rodrigo","family":"Oliveira Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-7129","authenticated-orcid":false,"given":"Tha\u00edsa","family":"Hanemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5128-3459","authenticated-orcid":false,"given":"Arthur","family":"Ossanai Schoenardie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-8924","authenticated-orcid":false,"given":"Andr\u00e9 Lucas","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-1617","authenticated-orcid":false,"given":"Juliana","family":"Catucci Boza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.04.006_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000136656","article-title":"Prevalence of skin diseases in a cohort of 48,665 employees in Germany","volume":"217","author":"Schaefer","year":"2008","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2023.04.006_bib0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaad.2008.10.062","article-title":"Trends in incidence of adult-onset psoriasis over three decades: a population-based study","volume":"60","author":"Icen","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3899\/jrheum.111246","article-title":"Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting","volume":"39","author":"Espinoza","year":"2012","journal-title":"J Rheumatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vhri.2021.05.004","article-title":"Burden of disease for Psoriasis in Argentina, Brazil, Colombia, and Mexico","volume":"26","author":"Papadimitropoulos","year":"2021","journal-title":"Value Health Reg Issues."},{"key":"10.1016\/j.abd.2023.04.006_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of chronic plaque Psoriasis and its intersection with cardio-metabolic comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.abd.2023.04.006_bib0030","doi-asserted-by":"crossref","first-page":"A568","DOI":"10.1016\/j.jval.2017.08.963","article-title":"Access to Psoriasis drug treatment among Brazilian patients","volume":"20","author":"Lopes","year":"2017","journal-title":"Value Health."},{"key":"10.1016\/j.abd.2023.04.006_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15381\/anales.v80i1.15623","article-title":"Incidencia de tuberculosis en pacientes con psoriasis que reciben terapias anti- TNF- alfa en Latinoam\u00e9rica: revisi\u00f3n sistem\u00e1tica y metaan\u00e1lisis","volume":"80","author":"Contreras Maza","year":"2019","journal-title":"An Fac Med."},{"key":"10.1016\/j.abd.2023.04.006_bib0040","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"10.1016\/j.abd.2023.04.006_bib0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2012 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev."},{"key":"10.1016\/j.abd.2023.04.006_bib0050","unstructured":"Joanna Briggs Institute [Internet]. Checklist for Systematic Reviews. 2017 [cited 2023 Mar 9]. Available from: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"10.1016\/j.abd.2023.04.006_bib0055","unstructured":"Joanna Briggs Institute [Internet]. Checklist for Prevalence Studies. 2017 [cited 2023 Mar 9]. Available from: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"10.1016\/j.abd.2023.04.006_bib0060","unstructured":"Joanna Briggs Institute [Internet]. Checklist for Analytical Cohort Studies. 2017 [cited 2023 Mar 9]. Available from: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"10.1016\/j.abd.2023.04.006_bib0065","unstructured":"Joanna Briggs Institute [Internet]. Checklist for Analytical Cross-Sectional Studies. 2017 [cited 2023 Mar 7]. Available from: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"10.1016\/j.abd.2023.04.006_bib0070","first-page":"85","article-title":"Perspectives of colombian patients with psoriasis on access to treatment and its repercussion on the social environment. An experience of Fundapso","volume":"33","author":"Usuga","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/abd1806-4841.20186069","article-title":"The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil","volume":"93","author":"Dibonaventura","year":"2018","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0080","doi-asserted-by":"crossref","first-page":"A567","DOI":"10.1016\/j.jval.2017.08.955","article-title":"Health Care Resource Utilization Among Patients with Moderate-To-Severe Plaque Psoriasis In Brazil","volume":"20","author":"Lopes","year":"2017","journal-title":"Value Health."},{"key":"10.1016\/j.abd.2023.04.006_bib0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1590\/S0034-8910.2014048005109","article-title":"Biological drugs for the treatment of psoriasis in a public health system","volume":"48","author":"Lopes","year":"2014","journal-title":"Rev Saude Publica."},{"key":"10.1016\/j.abd.2023.04.006_bib0090","doi-asserted-by":"crossref","first-page":"e8064","DOI":"10.5867\/medwave.2020.10.8064","article-title":"Caracterizaci\u00f3n cl\u00ednica y epidemiol\u00f3gica de pacientes con psoriasis y prescripci\u00f3n de terapia biol\u00f3gica en Venezuela: estudio transversal","volume":"20","author":"Rojano Rada","year":"2020","journal-title":"Medwave."},{"key":"10.1016\/j.abd.2023.04.006_bib0095","unstructured":"Figueroa P, Barbini C, Parigini A, Eimer I, Suar I, De Pablo A, et al. Prevalence and incidence of latent tuberculosis in patients with moderate to severe psoriasis under systemic treatment in the Dermatology Service of the Hospital Universitario Austral. [Internet]. [cited 2023 Apr 13]. Available from: https:\/\/www.wcd2019milan-dl.org\/abstract-book\/documents\/abstracts\/35-psoriasis\/prevalence-and-incidence-of-latent-2177.pdf."},{"key":"10.1016\/j.abd.2023.04.006_bib0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/09546634.2016.1151857","article-title":"Isoniazid toxicity and TB development during biological therapy of patients with psoriasis in Colombia","volume":"27","author":"Cata\u00f1o","year":"2016","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2023.04.006_bib0105","unstructured":"Tanaka Gon\u00e7alves L, Vicente Cesetti M, Shu Kurizky P, Ferra\u00e7o Marianelli F, Suelen Jacques Sousa De Assis F, Aparecida De Paula N, et al. Identification of Mycobacterium leprae DNA in psoriasis and\/or psoriatic arthritis patients under immunobiological therapy [Internet]. [cited 2023 Apr 13]. Available from: https:\/\/www.wcd2019milan-dl.org\/abstract-book\/documents\/abstracts\/22-infectious-diseases\/identification-of-mycobacterium-leprae-dna-5556.pdf."},{"key":"10.1016\/j.abd.2023.04.006_bib0110","unstructured":"Secretaria de Sa\u00fade do Distrito Federal [Internet]. Subsecretaria de Vigil\u00e2ncia \u00e0 Sa\u00fade. Situa\u00e7\u00e3o epidemiol\u00f3gica da Hansen\u00edase no Distrito Federal. 2022 [cited 2023 Apr 9]. Available from: https:\/\/www.saude.df.gov.br\/documents\/37101\/0\/INFORMATIVO+HANSENIASE+2022.pdf\/840d5df2-ff5e-8905-a2e7-3a599a3ea2e5?t=1656007581564."},{"key":"10.1016\/j.abd.2023.04.006_bib0115","first-page":"285","article-title":"Estudio sobre la infecci\u00f3n por el virus de la hepatitis C en pacientes con psoriasis de un centro de refer\u00eancia de Brasil","volume":"42","author":"Andrade","year":"2012","journal-title":"Acta Gastroenterol Latinoam."},{"key":"10.1016\/j.abd.2023.04.006_bib0120","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/bjd.18262","article-title":"Cross-sectional screening study for Leishmania DNA and antibodies in biologic-treated patients with psoriasis living in an area endemic for leishmaniasis","volume":"181","author":"Kurizky","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0125","first-page":"149","article-title":"Surveillance of Visceral Leishmaniasis in the Federal District: organizational aspects, epidemiological situation and intersectoral measures","volume":"28","author":"Silva","year":"2017","journal-title":"Com Ci\u00eanc Sa\u00fade."},{"key":"10.1016\/j.abd.2023.04.006_bib0130","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1111\/ijd.14785","article-title":"Zika, chikungunya, and dengue infections as exacerbating factors of psoriasis in patients receiving biological therapy","volume":"59","author":"Araujo","year":"2020","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0135","unstructured":"Almeida P, Giordano C, Ger\u00eancia de Doen\u00e7as Transmitidas por Vetores e Zoonoses. Boletim Epidemiol\u00f3gico Arboviroses [Internet]. Secretaria de Estado de Sa\u00fade do Rio de Janeiro. 2017 [cited 2023 Apr 10]. Available from: http:\/\/www.riocomsaude.rj.gov.br\/Publico\/MostrarArquivo.aspx?C=7eeHrPVyjGk%3D."},{"key":"10.1016\/j.abd.2023.04.006_bib0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-4632.2011.05037.x","article-title":"Self-medication and adherence to treatment in psoriasis","volume":"51","author":"Kivelevitch","year":"2012","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0145","first-page":"305","article-title":"Late diagnosis of psoriasis: Reasons and consequences","volume":"153","author":"Quiroz-Vergara","year":"2017","journal-title":"Gac Med Mex."},{"key":"10.1016\/j.abd.2023.04.006_bib0150","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s12325-019-01049-7","article-title":"Humanistic and economic impact of moderate to severe plaque Psoriasis in Brazil","volume":"36","author":"Lopes","year":"2019","journal-title":"Adv Ther."},{"key":"10.1016\/j.abd.2023.04.006_bib0155","doi-asserted-by":"crossref","first-page":"A226","DOI":"10.1016\/j.jval.2014.03.1322","article-title":"Economic burden of Psoriatic patients in the brazilian health system","volume":"17","author":"Ferreira","year":"2014","journal-title":"Value Health."},{"key":"10.1016\/j.abd.2023.04.006_bib0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/09546634.2017.1329503","article-title":"Real-world prescription trends of methotrexate for psoriasis in Argentina: results of a national survey","volume":"28","author":"Mazzuoccolo","year":"2017","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2023.04.006_bib0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004179","article-title":"Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil","volume":"4","author":"Silveira","year":"2014","journal-title":"BMJ Open."},{"key":"10.1016\/j.abd.2023.04.006_bib0170","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.abd.2021.03.007","article-title":"Brazilian consensus on Psoriasis 2020 and treatment algorithm of the Brazilian Society of Dermatology","volume":"96","author":"Romiti","year":"2021","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0175","unstructured":"Minist\u00e9rio da Sa\u00fade. Relat\u00f3rio de recomenda\u00e7\u00e3o: Protocolos Cl\u00ednicos e Diretrizes Terap\u00eauticas - Psor\u00edase [Internet]. Bras\u00edlia; 2021 Aug [cited 2023 Mar 7]. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/protocolos-clinicos-e-diretrizes-terapeuticas-pcdt\/arquivos\/2019\/PortariaConjuntan18de14102021_PCDT_Psoriase.pdf."},{"key":"10.1016\/j.abd.2023.04.006_bib0180","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/bjd.15234","article-title":"Inequalities in access to biological treatments for psoriasis: results from the Italian Psocare registry","volume":"176","author":"Naldi","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0185","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2340\/00015555-2625","article-title":"Socioeconomic inequalities and severity of plaque Psoriasis at a first consultation in Dermatology centers","volume":"97","author":"Mah\u00e9","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0190","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/jid.2015.296","article-title":"Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use","volume":"135","author":"Takeshita","year":"2015","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09546634.2011.631979","article-title":"How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center","volume":"24","author":"Kamangar","year":"2013","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2023.04.006_bib0200","unstructured":"Minist\u00e9rio da Sa\u00fade. Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais 2020 [Internet]. Bras\u00edlia; 2020 [cited 2023 Apr 13]. Available from: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/relacao_medicamentos_rename_2020.pdf."},{"key":"10.1016\/j.abd.2023.04.006_bib0205","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/bjd.13539","article-title":"Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry","volume":"172","author":"Gisondi","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bjd.17693","article-title":"Screening for hepatitis B virus and tuberculosis infection in patients with moderate\u2010to\u2010severe psoriasis recruiting for biological therapy in China","volume":"181","author":"Sun","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0215","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/idoj.IDOJ_698_20","article-title":"Latent tuberculosis in psoriasis patients planned for systemic therapy \u2013 a prospective observational study","volume":"12","author":"Neema","year":"2021","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.abd.2023.04.006_bib0220","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/ijd.12522","article-title":"Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON\u00ae -TB Gold In-Tube test and tuberculin skin test","volume":"53","author":"Duman","year":"2014","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/09546634.2018.1443198","article-title":"Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review","volume":"29","author":"Lee","year":"2018","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2023.04.006_bib0230","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/jdv.12011","article-title":"Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry","volume":"27","author":"S\u00e1nchez-Moya","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0235","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.13130","article-title":"Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy","volume":"171","author":"Gisondi","year":"2014","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0240","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ijd.12628","article-title":"The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents","volume":"54","author":"Ergun","year":"2015","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0245","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jdv.13633","article-title":"Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study","volume":"30","author":"Guinard","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0250","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0365-05962011000400014","article-title":"Investiga\u00e7\u00e3o de infec\u00e7\u00e3o tuberculosa latente em pacientes com psor\u00edase candidatos ao uso de drogas imunobiol\u00f3gicas","volume":"86","author":"Lima","year":"2011","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","article-title":"Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis","volume":"17","author":"Auguste","year":"2017","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.abd.2023.04.006_bib0260","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4269\/ajtmh.19-0616","article-title":"Biologics in Leprosy: a systematic review and case report","volume":"102","author":"Cogen","year":"2020","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.abd.2023.04.006_bib0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/abd1806-4841.20132187","article-title":"Biological agents: investigation into leprosy and other infectious diseases before indication","volume":"88","author":"Ant\u00f4nio","year":"2013","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0270","first-page":"55","article-title":"Epidemiology and treatment of psoriasis: a Brazilian perspective","volume":"5","author":"Duarte","year":"2015","journal-title":"Psoriasis (Auckl)."},{"key":"10.1016\/j.abd.2023.04.006_bib0275","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1590\/s1678-9946202062028","article-title":"A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases","volume":"62","author":"Kurizky","year":"2020","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"10.1016\/j.abd.2023.04.006_bib0280","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/ddg.15007","article-title":"Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-\u03b1 inhibitors","author":"Palacios-Diaz","year":"2023","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.abd.2023.04.006_bib0285","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000360284","article-title":"Self-medication of Psoriasis in southwestern China","volume":"228","author":"Zhang","year":"2014","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2023.04.006_bib0290","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1468-3083.2006.01565.x","article-title":"Adherence to treatment in patients with psoriasis","volume":"20","author":"Richards","year":"2006","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0295","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1468-3083.2007.02425.x","article-title":"Adherence to treatment in patients with psoriasis vulgaris: Turkish experience","volume":"22","author":"Gokdemir","year":"2008","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-13-9","article-title":"Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study","volume":"13","author":"Khalid","year":"2013","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2133.2006.07354.x","article-title":"The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial","volume":"155","author":"Griffiths","year":"2006","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0310","article-title":"Management of a chronic skin disease in primary care: an analysis of early-career general practitioners\u2019 consultations involving Psoriasis","volume":"11","author":"Nawaz","year":"2021","journal-title":"Dermatol Pract Concept."},{"key":"10.1016\/j.abd.2023.04.006_bib0315","first-page":"5","article-title":"Psoriasis and comorbidities: general practitioners\u2019 awareness","volume":"27","author":"Costa-Silva","year":"2018","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"key":"10.1016\/j.abd.2023.04.006_bib0320","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bjd.18798","article-title":"A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis","volume":"183","author":"Villacorta","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0325","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027535","article-title":"Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry","volume":"9","author":"Strober","year":"2019","journal-title":"BMJ Open."},{"key":"10.1016\/j.abd.2023.04.006_bib0330","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/ced.12841","article-title":"Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA","volume":"41","author":"Korman","year":"2016","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2023.04.006_bib0335","first-page":"1506","article-title":"The relationship between disease, work and sickness absence among Psoriasis patients","volume":"44","author":"Mansouri","year":"2015","journal-title":"Iran J Public Health."},{"key":"10.1016\/j.abd.2023.04.006_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052935","article-title":"Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011","volume":"7","author":"Armstrong","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.abd.2023.04.006_bib0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00403-015-1567-x","article-title":"Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis","volume":"307","author":"Schmitt","year":"2015","journal-title":"Arch Dermatol Res."},{"key":"#cr-split#-10.1016\/j.abd.2023.04.006_bib0350.1","unstructured":"Ablada V. Taxa de desemprego no pa\u00eds fecha 2017 em 12,7%"},{"key":"#cr-split#-10.1016\/j.abd.2023.04.006_bib0350.2","unstructured":"popula\u00e7\u00e3o desocupada cai 5% [Internet]. Ag\u00eancia Brasil. 2018 [cited 2023 Mar 7]. Available from: https:\/\/agenciabrasil.ebc.com.br\/economia\/noticia\/2018-01\/taxa-de-desemprego-no-pais-fecha-2017-em-127."},{"key":"10.1016\/j.abd.2023.04.006_bib0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/09546634.2018.1506077","article-title":"A cross-sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity","volume":"30","author":"Bronckers","year":"2019","journal-title":"J Dermatol Treat."},{"key":"10.1016\/j.abd.2023.04.006_bib0360","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/jdv.12233","article-title":"The impact of psoriasis on work-related problems: a multicenter cross-sectional survey","volume":"28","author":"Ayala","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.04.006_bib0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000102033","article-title":"Dermatologists\u2019 adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey","volume":"215","author":"Berends","year":"2007","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2023.04.006_bib0370","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jdv.12495","article-title":"Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists","volume":"29","author":"Gyulai","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623002568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623002568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:51Z","timestamp":1747666851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059623002568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0365059623002568"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.04.006","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet needs in the management of psoriasis in Latin America: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}